US EditionWhich embolic to use during portal vein embolization - Interventional News
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Which embolic to use during portal vein embolization - Interventional News
José Hugo Luz Portal vein embolization (PVE) is a crucial preoperative procedure designed to induce hypertrophy of the future liver remnant (FLR) in patients requiring major hepatectomy. Among the embolic agents available, n-butyl cyanoacrylate (nBCA) combined with lipiodol has emerged as one of the most effective options for PVE, shares José Hugo Luz (Brazilian National Cancer Institute, Rio de Janeiro, Brazil), promoting a high yield of liver …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
